CTNM

NASDAQ:CTNM

Contineum Therapeutics

  • Stock

USD

Last Close

11.01

06/11 21:00

Market Cap

541.73M

Beta: -

Volume Today

132.52K

Avg: -

PE Ratio

−20.64

PFCF: −17.65

OverviewFinancialsAPI
Income StatementBalance SheetCash FlowKey MetricsRatios
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '21
Dec '22
Dec '23
Dec '24
revenue
50M
-
cost of revenue
329K
-
195K
40.73%
gross profit
-329K
-
49.80M
15,238.30%
selling and marketing expenses
-329K
-
-195K
40.73%
general and administrative expenses
6.29M
-
5.83M
7.33%
6.32M
8.48%
12.47M
97.34%
selling general and administrative expenses
6.29M
-
5.50M
12.57%
6.13M
11.42%
12.47M
103.62%
research and development expenses
22.36M
-
16.89M
24.45%
27.60M
63.39%
38.42M
39.20%
other expenses
-91K
-
-92K
1.10%
-177K
92.39%
cost and expenses
28.65M
-
22.72M
20.69%
33.92M
49.31%
50.89M
50.03%
operating expenses
28.65M
-
22.39M
21.84%
33.73M
50.63%
50.89M
50.90%
interest expense
332K
-
388K
16.87%
208K
46.39%
ebitda
-28.34M
-
-22.39M
20.98%
16.27M
172.67%
-42M
358.11%
operating income
-28.65M
-
-22.72M
20.69%
16.08M
170.76%
-50.89M
416.56%
depreciation and amortization
325K
-
329K
1.23%
195K
40.73%
258K
32.31%
total other income expenses net
-99K
-
-1.53M
1,448.48%
7.09M
562.69%
8.64M
21.75%
income before tax
-29.00M
-
-24.25M
16.37%
23.17M
195.53%
-42.26M
282.38%
income tax expense
241K
-
450K
-
net income
-29.00M
-
-24.25M
16.37%
22.72M
193.68%
-42.26M
285.99%
weighted average shs out
16.67M
-
25.13M
50.72%
25.13M
0%
19.35M
22.99%
weighted average shs out dil
17.76M
-
25.13M
41.50%
25.13M
0%
19.35M
22.99%
eps
-1.74
-
-0.97
44.25%
0.13
113.40%
-2.18
1,776.92%
epsdiluted
-1.63
-
-0.97
40.49%
0.13
113.40%
-2.18
1,776.92%

All numbers in USD (except ratios and percentages)